Merck & Co Inc
NYSE: MRK
$96.31
-$2.05 (-2.1%)
Closing Price on November 15, 2024
MRK Articles
Biotech and pharma companies were on the move Wednesday. A few of the smaller caps made tremendous gains on the day, while a couple of the major firms saw massive volume and a slight move. Although...
Published:
Last Updated:
The DJIA bull-bear projection of 21,422 would be short of the preliminary look of 22,000 seen at the end of December, but another 8.4% gain likely would be more than welcome.
Published:
Last Updated:
There is an investment vehicle that may offer investors a way to stay in equities, get paid solid dividends and have the potential for outperforming total return.
Published:
Last Updated:
Major Dow Jones Industrial Average companies in the health care sector saw a relatively strong 2016, with most posting a solid gain on the year.
Published:
Last Updated:
A slimmer portfolio is expected to pay off for Procter & Gamble investors as the company now focuses on 10 product categories where it has about 65 category-leading brands.
Published:
Last Updated:
ThinkstockJanuary 3, 2017: Markets opened higher Tuesday following the beginning of promised cuts to crude oil production by OPEC members and other nations as well as a strong report on manufacturing...
Published:
Last Updated:
One strategy that has been quite common as investors rebalance and make changes each year is the Dogs of the Dow. Meet the 2017 Dogs of the Dow!
Published:
Last Updated:
December 28, 2016: Markets opened higher Wednesday but any recovery from Tuesday’s end-of-day selling failed to materialize. Trading reversed course from Tuesday, where every S&P sector showed...
Published:
Last Updated:
The December 15 short interest data have been compared with the previous figures, and short interest increased in most of these selected pharmaceutical stocks.
Published:
Last Updated:
December 21, 2016: Markets opened mixed Wednesday and the consensus opinion seems to be that traders are pausing to think about whether they really want the DJIA to top 20,000. It’s really just a...
Published:
Last Updated:
Monday’s top analyst upgrades, downgrades and initiations include Anadarko Petroleum, Bristol-Myers Squibb, Comcast, Walt Disney and Merck.
Published:
Last Updated:
At the end of each year, investors look for opportunities and safe harbors to park their money for the year ahead. Investors who love dividends often consider the so-called Dogs of the Dow.
Published:
Last Updated:
The November 30 short interest data have been compared with the previous figures, and short interest decreased in these selected pharmaceutical stocks.
Published:
Last Updated:
December 9, 2016: Markets opened higher again Friday with little support from either economic data or corporate earnings. One big positive came from the University of Michigan’s consumer sentiment...
Published:
Last Updated:
With the top pharmaceutical stocks trailing the market by a large margin, they are starting to look very attractive for long-term growth and income investors.
Published:
Last Updated: